Oncology medications are high-risk due to complexity of patient care and patient polypharmacy. This review and meta-analysis highlights the impact of randomized control studies employing pharmacist-led interventions in oncology. Despite the heterogeneity of the included studies, pharmacist interventions can reduce medication errors in oncology. More research is required in low- and middle-income countries.